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Type A Behavior and Risk of All-Cause
Mortality, CAD, and CAD-Related
Mortality in a Type 1 Diabetic
Population
22 years of follow-up in the Pittsburgh Epidemiology of Diabetes
Complications Study
CATHERINE E. FICKLEY, MPH, CPH1
CATHY E. LLOYD, PHD2
TINA COSTACOU, PHD1
RACHEL G. MILLER, MS1
TREVOR J. ORCHARD, MD, MMEDSCI, FAHA1
OBJECTIVEdTo determine whether type A behavior predicts all-causemortality and incident
coronary artery disease (CAD) in a type 1 diabetic population.
RESEARCHDESIGNANDMETHODSdFollow-up data (22 years) from the Pittsburgh
Epidemiology of Diabetes Complications (EDC) study of childhood-onset type 1 diabetes were
analyzed for the 506 participants who completed the Bortner Rating Scale (measuring type A
behavior) and Beck Depression Inventory (BDI) at baseline (1986–1988). CAD comprised myo-
cardial infarction as determined by hospital records/Q waves on electrocardiogram (ECG), CAD
death (determined by a mortality classiﬁcation committee), angiographic stenosis, ischemic
ECG, and angina.
RESULTSdThere were 128 deaths (25.3%) during follow-up. Univariate analysis showed an
inverse relationship between Bortner scores and all-cause mortality (P = 0.01), which remained
signiﬁcant after allowing for age, sex, duration, HbA1c, education, smoking, BMI, and physical
activity (P = 0.03). However, the addition of BDI scores attenuated the relationship (P = 0.11)
with a signiﬁcant interaction (P = 0.03) such that any protective effect against mortality was
limited among individuals with lower BDI scores (bottom three quintiles) (P = 0.07), whereas no
effect was seen in those with higher BDI (P = 0.97). Bortner scores showed only a borderline
association with incident CAD (P = 0.09).
CONCLUSIONSdThose with higher type A behavior have lower all-cause mortality in our
type 1 diabetic population, an effect that interacts with depressive symptomatology such that it is
only operative in those with low BDI scores. Further research should focus on understanding this
interaction.
The incidence of type 1 diabetes,which remains incurable, has con-tinued to rise annually by ;3% (1).
Unfortunately, prevention is not cur-
rently feasible. Therefore, the exploration
of type 1 diabetes complications, un-
timely mortality and the associated risk
factors, must continue. Type A behavior
has been described as an action-emotion
complex, meaning that the behavior is eli-
cited by the outside environment (2).
People characterized as having type A be-
havior tend to focus toward achieving and
accomplishingmore in less time than oth-
ers. Because of these tendencies, these
people tend to be competitive, aggressive,
time urgent, and work oriented and can
become annoyed if things are not achieved
in a time frame they ﬁnd sufﬁcient (2).
Therefore, it seems that type A behaviors
are not a set of personality characteristics
that come about due to the environment;
rather, the behavior is a result of predispo-
sitions within a person that are exhibited
due to speciﬁc situations (2). In an earlier
review, Matthews et al. (2) noted that al-
though type A behavior was linked to in-
creased coronary heart disease (CHD) risk
in the general population, ﬁndings were
consistently negative in high-risk popula-
tions. For example, the prospective West-
ern Collaborative Group Study (WCGS)
found that those with type A behavior ex-
perienced an increased rate of CHD com-
pared with type B behavior (P = 0.001) (3).
However, in their high-risk population
who had already undergone a CHD event,
typeAbehavior had a lowerCHD-associated
mortality rate in those surviving 24 h or
more than those characterized as having
type B behavior (P = 0.03) (4). Therefore,
it appears that type A behavior may have
different effects on health depending on
underlying chronic disease status.
Little is known about the psychoso-
cial contribution to the increased coro-
nary artery disease (CAD) risk seen in
people with type 1 diabetes beyond de-
pression (5,6), in particular, whether type
1 diabetes is an additional high-risk group
in which the inverse association between
type A behavior and CAD/mortality exists.
Cross-sectional data from the Pittsburgh
Epidemiology of Diabetes Complications
(EDC) study have shown (using the Bortner
Rating Scale) that participantswithmultiple
complications, including CAD, retinopa-
thy, neuropathy, and/or nephropathy, re-
ported less type A behaviors than those
without complications (P , 0.05) (5).
The long length of follow-up now avail-
able in the EDC allowed a prospective
analysis of the role of type A behavior in
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mortality and CAD, andwe are unaware of
other investigations of this relationship.
We also investigated the association be-
tween type A behavior and CAD-related
mortality in those already diagnosed
with CAD and whether the established ef-
fect of depressive symptomatology on
CAD incidence interacted with or ex-
plained any effect of type A behavior.
Thus, the aims of the current study were
to investigate the relationships between
type A behavior and mortality, type A be-
havior and incident CAD, and type A be-
havior and mortality among those with
CAD during 22 years of follow-up.
RESEARCH DESIGN AND
METHODSdThe EDC study is com-
prised of participants diagnosed with type
1 diabetes between 1950 and 1980 at
,17 years of age, seen within 1 year of
diagnosis at the Children’s Hospital of
Pittsburgh. Biennial follow-up occurred
since baseline in 1986–1988, which in-
cluded questionnaires with physician ex-
aminations and laboratory analyses of
urine and blood for the ﬁrst 10 years
and again at 18 years. Data up to the
22-year follow-up are now available. Par-
ticipants $18 years of age at study entry
completed the Bortner Rating Scale,
which measures aspects of type A behav-
ior (7) and has been shown to have good
test-retest reliability (2). Participants were
asked to circle the dot on the line that
represents where they believed they fell
between two different sentences. Some ex-
amples of the sentences included “never
late” versus “casual about appointments,”
“always rushed” versus “never rushed,
even under pressure,” and “take things
one at a time” versus “try to domany things
at once, thinking about what I am going to
do next.” CAD was deﬁned as myocardial
infarction conﬁrmed by hospital records or
Q waves on electrocardiogram (Minnesota
Code 1.1 or 1.2); coronary artery stenosis,
deﬁned as$50% blockage, or revasculari-
zation; ischemic electrocardiogram, de-
ﬁned using Minnesota Code 1.3, 4.1–4.3,
5.1–5.3, or 7.1; angina, diagnosed by an
EDC physician; or CAD death (determined
by a mortality classiﬁcation committee).
Overall mortality, including CAD-
associated mortality and complication
status, was determined as of 25 February
2011. Searches were performed in both
the Social Security Death Index and the
National Death Index. In order to conﬁrm
each death, death certiﬁcates were ob-
tained, plus, as appropriate, 1) hospital
records, 2) autopsy/coroner reports, and
3) interviewwith next of kin regarding the
death. The underlying causes of death,
and the hierarchal order for all contribut-
ing causes of death, were determined by a
Mortality Classiﬁcation Committee con-
sisting of two or more physician epidemi-
ologists. This method is based on
standardized procedures (8).
The following covariates were chosen
as potential predictors for our ﬁnal model:
age, sex, duration, education, physical
activity, smoking, BMI, insulin dosage,
HbA1c, and depressive symptomatology.
These covariates were chosen because
they are previously demonstrated risk fac-
tors for CAD and/or early mortality in type
1 diabetes (9). Education was assessed
using a ﬁve-point scale, i.e.: some high
school, high school graduate, some college,
bachelor’s degree, and graduate education
beyond bachelor’s. Physical activity was as-
sessed using questions about current levels
of leisure activities (10), as well as by esti-
mating the energy expenditure over the
past week (kcal/week) through use of ques-
tions asking about the daily number of
ﬂights of stairs climbed, the number of
blocks walked daily, and all sports partici-
pation that had occurred over the past
week. Ever smoked was deﬁned as having
had.100 cigarettes over their lifetime. In-
sulin dosage was expressed as the number
of units of insulin used per day divided by
the participant’s weight in kilograms. BMI
was calculated as participant’s weight in
kilograms divided by the square of their
height in meters. Fasting blood samples
were analyzed for HbA1 (microcolumn cat-
ion exchange; Isolab, Akron, OH), and
these original HbA1 values were converted
to Diabetes Complications and Control
Trial (DCCT)–alignedHbA1c for all analyses
using a regression equation derived from
duplicate assays (DCCT HbA1c = 0.14 +
0.83[EDC HbA1]). Finally, depressive
symptomatology was measured using the
Beck Depression Inventory (BDI) (11). The
BDI is a 21-item self-report scale that is
widely used in both healthy and ill popu-
lations. A score of 0–9 indicates minimal
depression, 10–18 indicates mild depres-
sion, 19–29 indicates moderate depres-
sion, and 30–63 indicates severe
depression (11). BDI scores have been
shown to approximate clinically signiﬁ-
cant symptoms of depression (11).
Cox proportional hazards models
were used to examine the univariate and
multivariable relationship between base-
line Bortner scores and overall mortality,
CAD incidence over 22 years of follow-
up, and CAD-related mortality among
those with CAD. To assess univariate
associations between baseline Bortner
score and potential covariates (i.e., age,
sex, duration, education, physical activ-
ity, smoking, BMI, insulin dosage, HbA1c,
and depressive symptomatology), Stu-
dent t test or Wilcoxon signed rank test
was used as appropriate. Cox propor-
tional hazards modeling was used to ex-
amine the independent association
between Bortner score and each out-
come (overall mortality, CAD incidence,
and incident CAD death among those
with CAD), adjusting for signiﬁcant
baseline covariates. All statistics were
performed using SAS 9.3 (SAS Institute,
Cary, NC).
RESULTSdAt the EDC baseline exam,
658 participants were seen. One hundred
and ﬁfty two participants were excluded
from this analysis for having missing
covariate measures; however, 60 of these
participants were ,18 years of age and
therefore not eligible to complete the
Bortner or the BDI, and an additional 92
participants were excluded, most com-
monly, formissingdata on the BDI, Bortner,
or physical activity measures.
As of 25 February 2011, of EDC
participants who completed both the
Bortner and the BDI at baseline, and who
had complete covariate data (n = 506, 250
males and 256 females), there were 128
deaths (25.3%). Those excluded were
less likely to have a high school education
(P = 0.01) and were more likely to be
smokers (P , 0.01), but did not differ
signiﬁcantly for age, duration, sex,




existed between those with and without
incident CAD for age, duration, physical
activity, smoking, BDI, and insulin dosage
(Table 1). A signiﬁcant trend was demon-
strated for both Bortner (P = 0.05) and BDI
score (P = 0.01) at baseline and CAD inci-
dence (Fig. 1A andC). A borderline univar-
iate relationship was seen between baseline
Bortner scores and CAD incidence (P =
0.09). No signiﬁcant interaction was ob-
served between Bortner and BDI in rela-
tion to CAD incidence.
Differences existed by subsequent
mortality for most baseline covariates.
Deceased participants tended to be older,
with longer diabetes duration, male, less
physically active, and ever smokers and
had a higher HbA1c and BDI score and a
lower Bortner score compared with
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survivors (Table 2). The univariate asso-
ciation between Bortner scores and all-
cause mortality is shown in more detail
by quintiles (P = 0.01) (Fig. 1B). Those
with higher type A behavior tended to be
at a reduced risk for mortality with a signif-
icant trend (P = 0.01). Multivariable ana-
lyses (Table 3) of the association between
type A behavior and all-cause mortality
were performedwith fourmodels, progres-
sively controlling for covariates. Model 1
was adjusted for age and sex, with Bortner
score remaining signiﬁcant (P = 0.01).
Model 2 included age, sex, duration,
HbA1c, education, smoking, BMI, and
physical activity as covariates and demon-
strated that Bortner score continued to sig-
niﬁcantly predict mortality (hazard ratio
[HR] 0.99 [95% CI 0.98–1.00]; P = 0.03).
For every one-point increase on the Bortner
scale, there was a 1% lower mortality risk
(Bortner Rating Scale range, 97–258).
However, further adjustment for BDI
(model 3) reduced the association between
Bortner and mortality (P = 0.11).
Model 4 tested for an interaction
between the Bortner Rating Scale and
BDI for mortality (Table 3) as a signiﬁcant
inverse correlation was found between
the two (r = 20.18, P , 0.001). This in-
teraction was signiﬁcant (P = 0.03), mean-
ing type A behavior is only operative in
those with lower BDI scores. Further BDI-
stratiﬁed analyses were then performed.
Based on the quintiles determined in our
study population (BDI scores: 0–1, 2–3,
4–6, 7–12, and 13–32) (Fig. 1D), we
compared the ﬁrst three quintiles with
the upper two quintiles, resulting in two
categories, a BDI score #6 versus a BDI
score$7. A borderline signiﬁcant protec-
tive effect against mortality was seen with
higher type A behavior score in the lower
BDI quintiles (P = 0.07), but not with a
BDI score $7 (P = 0.97).
Performing analyses by sex (mean
Bortner score in men, 191.1, vs. women,
185.2; P , 0.01), a signiﬁcant univariate
relationship between Bortner andmortality
(0.98 [0.97–0.99]; P, 0.001) was seen in
men but not in women (0.99 [0.98–1.00];
P = 0.12). However, a greater proportion of
men than women were type A within our
population (P = 0.03). The signiﬁcant re-
lationship amongmen remained after mul-
tivariable adjustment (0.99 [0.98–0.99];
P = 0.03) but was attenuated after further
adjusting for BDI (0.99 [0.98–1.00]; P =
0.10). A signiﬁcant interaction between
Bortner and BDI (P = 0.03) was noted,
although stratiﬁcation by the same cut
points of BDI as above did not yield any
signiﬁcant differences. Stratifying by mini-
mal to mild versus moderate to severe de-
pressive symptoms, however, demonstrated
that men with aminimal to mild BDI score
(0.98 [0.97–0.99]; P = 0.02) were protected
against mortality compared with those
with a moderate to severe BDI score (1.00
[0.97–1.04]; P = 0.63) in multivariable
analyses.
Out of 506 participants, there were
64 CAD-related deaths (12.6%). We
found that Bortner signiﬁcantly predicted
CAD mortality (0.99 [0.98–1.00]; P =
0.04). The analyses were subsequently re-
peated excluding non-CAD deaths from
the control group (essentially comparing
survivors to CAD death [14.3%]), and a
signiﬁcant relationship between Bortner
score and CAD death was found as well
(0.98 [0.97–0.99]; P = 0.03).
We then examined the predictive
value of the Bortner Rating Scale for
CAD mortality in those with prevalent
CAD. No univariate association was
found with death among those with
CAD within 22 years of follow-up (P =
0.35).
CONCLUSIONSdWe observed a sig-
niﬁcant relationship between Bortner
scores and all-cause mortality, which
was attenuated after adjustment for BDI.
We also noted the presence of signiﬁcant
effect modiﬁcation of the relationship
between the Bortner and mortality by
BDI score. Thus, a borderline signiﬁcant
inverse association between type A be-
havior and mortality was only apparent
among those in the bottom three BDI
quintiles, whereas this relationship was
lost in the top two quintiles. Analyses
stratifying by sex suggested that only men
were protected against mortality with a
higher type A behavior score, even after
adjustment for BDI. However, stratifying
by BDI revealed a protective effect of type
A behavior only in those with minimal to
mild, but not moderate to severe, depres-
sive symptoms. We found a borderline
signiﬁcant relationship between Bortner
scores and incident CAD, which was
attenuated after adjustment for duration.
To our knowledge, this is the ﬁrst
study to investigate the relationship be-
tween type A behavior and all-cause
mortality in a type 1 diabetic population.
The strengths of our study are the long
follow-up and the completeness of data
obtained for our population. In addition to
demonstrating the importance of type A
behavior and depressive symptomatology,
our results afﬁrm the role traditional, im-
portant covariates play on CAD develop-
ment and early mortality in type 1
diabetes. Those with the highest type A
behavior scores were at the lowest mor-
tality risk, which is consistent with most
Table 1dBaseline characteristics by CAD incidence, 1986–1988
No incident CAD (n = 331) Incident CAD (n = 176) P value
Age 26.7 (6.3) 32.1 (6.5) ,0.0001
Sex, % (n), males 47.1 (156) 54.0 (95) 0.14
Duration 17.9 (6.6) 23.6 (6.9) ,0.0001
Education, % (n), above high school 65.8 (212) 60.7 (105) 0.25
Total energy expenditure/week (kcal) 1583.0 (646.0–2961.0)† 1149.0 (448.0–2238.0)† ,0. 01
Total sports expenditure/week 450.0 (0.0–1500.0)† 0.0 (0.0–630.0)† ,0.0001
Smoke ever, % (n), yes 32.5 (107) 50.8 (89) ,0.0001
BMI 23.4 (21.6–25.4)† 23.7 (21.9–26.1)† 0.25
HbA1c, % (mmol/mol) 8.6 (1.5) (70 [16.4]) 8.7 (1.4) (72 [15.3]) 0.72
Insulin dosage (total units/weight) 0.79 (0.24) 0.73 (0.23) 0.01
Bortner Rating Scale 190.1 (25.2) 186.2 (24.6) 0.09
BDI 5.0 (2.0–10.0)† 6.0 (3.0–11.0)† 0.01
†Median (interquartile range).
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of the literature demonstrating that high-
risk populations are protectedwith greater
type A behavior (2,3,5). However, with
the addition of BDI to our model, this re-
lationship was attenuated. After determin-
ing that the Bortner scale and BDI were
inversely correlated, we tested for an in-
teraction between them to determine if the
protective effect we observed from high
type A behavior was really due to the
low depressive symptomatology score in
this group. The interaction term was sig-
niﬁcant, suggesting that type A behavior
may be protective against mortality in the
absence of depressive symptomatology
(although this was only borderline signif-
icant). Any protection from type A behav-
ior appears to be lost once the higher
quintiles of depressive symptomatology
are reached. This suggests that depressive
symptomatology is a stronger predictor of
mortality than type A behavior in type 1
diabetes. Indeed, the death rate was 17.8%
in the bottom three quintiles, approxi-
mately two times lower than in the top
two quintiles, at 34.5%.
The importance of depressive symp-
tomatology in type 1 diabetes is expected,
as it has been frequently demonstrated
that those with high depressive symptom-
atology are at an increased mortality (12)
and morbidity risk (including diabetes
complications) (13). Comorbid depression
and type 1 diabetes is also associated with
poorer diabetes self-management and met-
abolic control, decreased quality of life, and
higher healthcare usage (12). Our previous
research showed that BDI score signiﬁ-
cantly predicted CHD even after control-
ling for hypertension, waist-to-hip ratio
(WHR), white blood cell count, ﬁbrinogen,
smoking status, distal symmetric polyneuro-
pathy, and overt nephropathy. However,
this relationship became attenuated after
the addition of all possible variables in the
mediation analysis (6). Depressive symp-
tomatology has also been found to increase
WHR inboth sexes (14) and appears to play
an important role in the incidence and pro-
gression of type 1 diabetes–associated com-
plications, as conﬁrmed in our study.
We hypothesized that Bortner scores
would continue to be predictive of mor-
tality, even after controlling for BDI,
Figure 1dA: Bortner quintiles and CAD rate. B: Bortner quintiles andmortality rate.C: BDI quintiles and CAD rate.D: BDI quintiles andmortality
rate
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particularly because individuals with di-
abetes have to adopt regimented control
along with other characteristic type A
behaviors, such as having to do many
things at once, thinking of what they might
need to do next, becoming less casual about
things, and feeling ambitious (7). Type A
behaviors may increase the efﬁciency in
which an individual cares for their type
1 diabetes, therefore preventing compli-
cations and early mortality. However, de-
pressive symptoms may outweigh the
signiﬁcance of type A behavior, as
demonstrated in our analysis. Adopting
type A behaviors in order to better care
for a chronic disease like type 1 diabetes
may also partially explain why type A be-
havior is protective in high-risk, as opposed
to the general, populations. Those with
greater type A behavior in the presence
of a chronic disease may treat symptoms
and suspected complications more seri-
ously and intensively than those character-
ized as having less type A behavior.
Little research exists on depressive
symptomatology and subsequent risk of
mortality in type 1 diabetes. The FinnDiane
Study Group concluded that in women,
baseline antidepressant agent purchase
(their surrogate marker for depression)
was associated with an increased mortality
risk over 9 years of follow-up (2.15 [1.34–
3.45]) (15). Although this association was
only seen in women, our results
demonstrate a similar relationship. Those
with increased depressive symptomatology
were not only at increased mortality risk,
but the protection offered by type A behav-
ior disappeared with increased BDI. De-
pressive symptoms, therefore, appear to
play a very important role in predicting
mortality in type 1 diabetes.
Investigating the association between
type A behavior and mortality by sex
showed that the protective effects of type A
behavior are only signiﬁcant in men. How-
ever, these ﬁndings may be partially attrib-
utable to a lack of power to detect the
relationship in women as fewer women
had a high type A score. The relationship
among men remained until BDI adjust-
ment.We compared those withminimal to
mild versus moderate to severe depressive
symptoms and found only those with high
type A behavior and less than moderate
depressive symptoms were protected
against mortality.
It has been previously noted that
because type A behavior questionnaires
can be interpreted as geared toward work
or competitive behaviors, men may re-
spond differently than women (2). In
other words, men may feel it is more so-
cially acceptable, expected, and ﬁtting of
their traditional role to declare themselves
as “very competitive,” “hard driving,” and
“ambitious” whereas women may not feel
the pressure to fulﬁll that stereotype.
Therefore, our male participants’ responses
Table 2dBaseline characteristics (1986–1988) by subsequent mortality
Living (n = 378) Deceased (n = 128) P value
Age 27.6 (6.5) 33.6 (6.3) ,0.0001
Sex, % (n), males 47.1 (178) 56.2 (72) 0.07
Duration 18.8 (6.8) 24.6 (6.5) ,0.0001
Education, % (n), above high school 65.6 (248) 60.1 (77) 0.26
Total energy expenditure/week (kcal) 1,531.0 (646.0–2,860.0)† 1,064.0 (336.0–2,059.0)† ,0.001
Total sports expenditure/week 400.0 (0.0–1,425.0)† 0.0 (0.0–512.5)† ,0.0001
Smoke ever, % (n), yes 33.3 (126) 57.0 (73) ,0.0001
BMI 23.5 (21.9–25.5)† 23.6 (21.0–26.3)† 0.91
HbA1c, % (mmol/mol) 8.6 (1.4) (70 [15.3]) 9.0 (1.6) (75 [17.5]) ,0.01
Insulin dosage (total units/kg body weight) 0.77 (0.22) 0.73 (0.29) 0.11
Bortner Rating Scale 190.0 (24.2) 182.5 (25.8) ,0.01
BDI 5.0 (2.0–10.0)† 8.0 (4.0–14.0)† ,0.0001
†Median (interquartile range).
Table 3dAssociation between type A behavior and all-cause mortality in type 1 diabetes
Covariate HR 95% CI P value AIC
Model 1a Bortner 0.99 0.98–0.99 0.01 1,464.84
Age 1.10 1.08–1.13 ,0.0001
Sex 0.65 0.46–0.93 0.01
Model 2b Bortner 0.99 0.98–0.99 0.04 1,434.22
Age 1.10 1.08–1.13 ,0.0001
Sex 0.70 0.49–0.99 0.05
Ever smoker 2.05 1.43–2.92 ,0.0001
HbA1c 1.32 1.17–1.48 ,0.0001
Model 3c Bortner 0.99 0.98–1.00 0.11 1,424.40
BDI 1.04 1.02–1.07 ,0.001
Age 1.10 1.07–1.13 ,0.0001
Sex 0.65 0.45–0.93 0.01
Ever smoker 2.00 1.40–2.85 ,0.001
HbA1c 1.29 1.15–1.45 ,0.0001
Model 4d Bortner 0.98 0.97–0.99 ,0.01 1,421.84
BDI 0.85 0.70–1.03 0.10
Age 1.11 1.08–1.13 ,0.0001
Sex 0.64 0.44–0.92 0.01
Ever smoker 1.93 1.35–2.76 ,0.001
HbA1c 1.28 1.15–1.43 ,0.0001
Bortner 3 BDI 1.001 1.000–1.002 0.03
Cox regression (n = 506; 128 events). HR (95% CI) for all-cause mortality per 1 unit change in Bortner score.
aModel 1 allowed for age, sex, and duration. bModel 2 allowed for model 1 + HbA1c, education, smoking,
and physical activity. cModel 3 allowed for model 2 + BDI as a continuous variable. dModel 4 allowed for
model 3 + Bortner and BDI interaction term. AIC, Akaike information criterion.
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on the Bortner scale may differ compared
with women due to social norms, espe-
cially in the 1980s when the questionnaire
was completed. At that time, if women
were homemakers, perhaps they felt they
were not facing the daily demands of a ca-
reer and therefore had less type A responses.
This is consistent with our data, as we
saw a statistically higher mean type A be-
havior score in men compared with
women (191.1 vs. 185.2; P , 0.01). A
study that also administered the Bortner
scale in the 1980s found that participants
with no or minimal obstructive CAD had
higher type A scores compared with those
with obstructive disease. After further
analysis by sex, the effect was only signif-
icant in men, consistent with our ﬁndings
(16).
We also examined the relationship
between Bortner scores and CAD as it is a
major contributor to death. In those free
of CAD at baseline, type A behavior
predicted CAD during 22 years of follow-
up, although this was of borderline statis-
tical signiﬁcance, and this relationship was
attenuated after adjustment for duration.
Thus, we did not ﬁnd that in our popula-
tion, increased type A behavior was pro-
tective against CAD or indeed CAD death
among those with CAD. Other factors not
measured in our study may play a role, and
further research is needed to determine
which other covariatesmay offer protection
against CAD. Our results were not as
hypothesized; however, it should be noted
that type A behavior was also not detri-
mental to the development of CAD, which
supports previous research in other high-
risk groups (2,3). Because type A behavior
was not related to CAD development, we
evaluated whether mortality was predicted
by Bortner scores based on whether the
primary cause of death was CAD or non-
CAD related. We found a signiﬁcant differ-
ence between these two groups, with type
A behavior protecting against CAD-related
death, and again when comparing CAD
death to survivors only.
A previous study by Lloyd et al. (5)
concluded that lower type A behavior
scores were associated with an increased
macrovascular disease risk; however, the
current study is the ﬁrst that we are aware
of to demonstrate that type A behavior in
type 1 diabetes is protective against CAD
death, speciﬁcally. In a 10-year follow-up
study of middle-aged, employed men,
speciﬁc personality traits that would be
considered type A did not predict CAD
death (17). The literature examining the
relationship between type A behavior and
CAD death is limited. Our remarkable
ﬁnding that type A behavior is speciﬁcally
protective against CAD death merits fur-
ther investigation.
Thus far, study ﬁndings examining
type A behavior in type 1 diabetes are
conﬂicting and often focused on surro-
gate outcomes (such as glycemic control
and complications) due to short length of
follow-up time. The results of studies
examining type A behavior and glycemic
control were mixed, with some suggest-
ing no association (18–20), others a
detrimental association (21,22), and
another a protective association of spe-
ciﬁc type A behaviors (i.e., neuroticism)
(23). However, the majority of these stud-
ies were conducted three decades ago
with large amounts of bias, which may
explain why mixed results were demon-
strated. The majority of the previously
published studies were conducted cross-
sectionally, using very small sample sizes,
and used univariate methods of analysis
only. Those that used multivariable ana-
lyses only controlled for a few relevant
covariates. Lloyd et al. (14) found that
those type 1 diabetic participants with
multiple complications reported less
type A behavior than those without any
complications (P , 0.05) (5). In a sepa-
rate study, it was also determined that in
men, lower type A behavior score was
predictive of an increased WHR. Because
type A behavior was not shown to be det-
rimental in type 1 diabetes, and protective
against complications as a whole and
WHR, our hypothesis was generated
that with longer follow-up, higher type
A behavior may be protective against
mortality. Future research needs to take
place to examine this relationship in other
high-risk populations.
Based on the literature that high-risk
groups are protected by their type A
behavior, we investigated the relationship
between the Bortner Rating Scale and
CAD case-fatality rate. We hypothesized
that in this very high-risk group of people
with both type 1 diabetes and CAD, type
A behavior would be even more protec-
tive, but a relationship was not found.
This may be due to several reasons, one
being that we may have had an insufﬁ-
cient sample size to ﬁnd a statistically
signiﬁcant result (28 deaths/125 with
CAD). Another reason may be that these
participants were too unhealthy to beneﬁt
from type A behavior at all, being that they
have both type 1 diabetes and a serious
complication. Another explanation may be
that the type A behaviors were initiated at
too late a time in life, and that type 1
diabetes and CAD had already done too
much physical damage for any protective
effect to take place against mortality. Per-
haps behavior type is also a trait and can
therefore be modiﬁed. If so, this has great
implications for care as we can support be-
havior change to improve self-management,
improving the health of those living with
diabetes.
There were several strengths and lim-
itations of our study. As mentioned pre-
viously, our long follow-up time allowed
for us to use mortality as our outcome, as
opposed to a surrogate end point such as
complication status. Additionally, this was
the ﬁrst study to investigate the relationship
between type A behavior and mortality in
type 1 diabetes, providing data where there
currently are none. Limitations of our study
include our small sample size for detecting
incident CAD death among those with
CAD, which may have led to null results.
Another limitation is the possibility of re-
sidual confounding; however, we feel we
included predictors that are essential for
investigating mortality in type 1 diabetes.
Furthermore, there were up to 22 years of
follow-up time between measuring type A
behavior and mortality and/or the onset of
CAD; however, we attempted to control for
this in the analysis through use of Cox
proportional hazards models.
In conclusion, future research is
needed to investigate the interaction be-
tween BDI and type A behavior, as the
latter was only protective in those with
low depressive symptomatology. Further
research is also needed to explore the
protective relationship between type A
behavior and CAD death. Understanding
these relationships is an important next
step in exploring the effects of psychoso-
cial factors onmortality in type 1 diabetes.
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